<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Phio Pharmaceuticals Corp.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Phio Pharmaceuticals Corp.

    Phio Pharmaceuticals is focused on developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYLTM) therapeutic platform. Immunotherapies harness our immune system to restore surveillance of tumors that evade detection – a potential curative medicine. INTASYLTM therapeutics can be used as a standalone treatment or in combination with other modalities. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Gerrit Dispersyn
    • FOUNDED
      2011
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Gulf Chronic Care Inc

    Gulf Chronic Care Inc

    Gulf Chronic Care, Inc. was established specifically to address the diabetic epide...

    Gulf Chronic Care, Inc. was established specifi...

    Filing Type:    RA
    BioHealthonomics Inc.

    BioHealthonomics Inc.

    BioHealthonomics Inc. is a research and development biotechnology & healthcare com...

    BioHealthonomics Inc. is a research and develop...

    Amount Raised:    $35,800
    Fundraising Status:    EC
    Filing Type:    CF
    Acadia Healthcare Company, Inc.

    Acadia Healthcare Company, Inc.

    Headquartered in Franklin, Tennessee, Acadia Healthcare was established in January...

    Headquartered in Franklin, Tennessee, Acadia He...

    Filing Type:    PU
    Liquidia Technologies, Inc.

    Liquidia Technologies, Inc.

    Liquidia is a late-stage clinical biopharmaceutical company focused on the develop...

    Liquidia is a late-stage clinical biopharmaceut...

    Filing Type:    PU
    Achieve Life Sciences, Inc.

    Achieve Life Sciences, Inc.

    Achieve is a specialty pharmaceutical company committed to advancing cytisinicline...

    Achieve is a specialty pharmaceutical company c...

    Filing Type:    PU
    Alexion Pharmaceuticals, Inc.

    Alexion Pharmaceuticals, Inc.

    Alexion (NASDAQ: ALXN) is a global biopharmaceutical company focused on serving pa...

    Alexion (NASDAQ: ALXN) is a global biopharmaceu...

    Filing Type:    PU
    Midatech Pharma PLC

    Midatech Pharma PLC

    Midatech is an international specialty pharmaceutical company focused on the devel...

    Midatech is an international specialty pharmace...

    Filing Type:    PU
    Iovance Biotherapeutics, Inc.

    Iovance Biotherapeutics, Inc.

    Iovance Biotherapeutics (formerly traded as Lion Biotechnologies) is focused on th...

    Iovance Biotherapeutics (formerly traded as Lio...

    Filing Type:    PU
    Neoleukin Therapeutics, Inc.

    Neoleukin Therapeutics, Inc.

    Neoleukin is a biopharmaceutical company creating next generation immunotherapies ...

    Neoleukin is a biopharmaceutical company creati...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.